Briaud Financial Planning’s Evotec EVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,160
Closed -$9K 111
2025
Q2
$9K Hold
2,160
﹤0.01% 246
2025
Q1
$7K Hold
2,160
﹤0.01% 146
2024
Q4
$8K Hold
2,160
﹤0.01% 141
2024
Q3
$7K Hold
2,160
﹤0.01% 110
2024
Q2
$10K Hold
2,160
0.01% 104
2024
Q1
$17K Buy
+2,160
New +$17K 0.01% 93
2023
Q4
Sell
-2,160
Closed -$21K 65
2023
Q3
$21K Buy
+2,160
New +$25.4K 0.02% 86

Other funds holding EVO

Briaud Financial Planning's EVO Position: Q3 2025 in Review

Briaud Financial Planning sold out of Evotec (EVO) in Q3 2025, closing a stake of 2,160 shares — an estimated $9K sold.

Briaud Financial Planning first reported a position in EVO in Q3 2023 and held it in 7 quarters. The position peaked at $21K in Q3 2023. 37 funds tracked by Wall St. Rank hold EVO as of Q3 2025.

  • Briaud Financial Planning reported no remaining Evotec position as of Q3 2025 after selling out during the quarter.
  • Briaud Financial Planning sold 2,160 Evotec shares in Q3 2025, an estimated $9K.
  • Briaud Financial Planning first reported a position in Evotec in Q3 2023 and held it in 7 quarters.
  • Briaud Financial Planning's Evotec position peaked at $21K in Q3 2023.
  • 37 funds tracked by Wall St. Rank held Evotec as of Q3 2025.

Based on Briaud Financial Planning's 13F filing for Q3 2025, filed 25 Nov 2025.